share_log

Olema Pharmaceuticals | 8-K/A: Current report (Amendment)

SEC announcement ·  Oct 18, 2023 16:46
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more